Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium falciparum | thioredoxin reductase | 0.0051 | 0.9855 | 1 |
Trypanosoma brucei | trypanothione reductase | 0.0051 | 0.9855 | 1 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0018 | 0.2763 | 0.2803 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0009 | 0.0846 | 0.3064 |
Chlamydia trachomatis | dihydrolipoyl dehydrogenase | 0.0018 | 0.2763 | 1 |
Trichomonas vaginalis | thioredoxin, putative | 0.0009 | 0.0846 | 0.3064 |
Brugia malayi | dihydrolipoyl dehydrogenase, mitochondrial precursor, putative | 0.0018 | 0.2763 | 0.2803 |
Echinococcus granulosus | thioredoxin mitochondrial | 0.0009 | 0.0846 | 0.0846 |
Brugia malayi | thioredoxin | 0.0009 | 0.0846 | 0.0859 |
Trichomonas vaginalis | mercuric reductase, putative | 0.0018 | 0.2763 | 1 |
Trichomonas vaginalis | thioredoxin f-type, putative | 0.0009 | 0.0846 | 0.3064 |
Plasmodium falciparum | glutathione reductase | 0.0051 | 0.9855 | 1 |
Mycobacterium ulcerans | thioredoxin TrxC | 0.0009 | 0.0846 | 0.3064 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0051 | 0.9855 | 1 |
Schistosoma mansoni | dihydrolipoamide dehydrogenase | 0.0018 | 0.2763 | 0.2763 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0018 | 0.2763 | 0.2803 |
Echinococcus granulosus | thioredoxin 2 | 0.0009 | 0.0846 | 0.0846 |
Plasmodium vivax | thioredoxin 1, putative | 0.0009 | 0.0846 | 0.0859 |
Brugia malayi | Pyridine nucleotide-disulphide oxidoreductase, dimerisation domain containing protein | 0.0013 | 0.1764 | 0.179 |
Leishmania major | 2-oxoglutarate dehydrogenase, e3 component, lipoamidedehydrogenase-like protein | 0.0018 | 0.2763 | 0.2803 |
Mycobacterium tuberculosis | Probable thioredoxin TrxB1 | 0.0009 | 0.0846 | 0.0859 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0018 | 0.2763 | 0.2803 |
Mycobacterium ulcerans | flavoprotein disulfide reductase | 0.0018 | 0.2763 | 1 |
Trichomonas vaginalis | thioredoxin, putative | 0.0009 | 0.0846 | 0.3064 |
Toxoplasma gondii | thioredoxin reductase | 0.0051 | 0.9855 | 1 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0018 | 0.2763 | 0.2803 |
Trichomonas vaginalis | thioredoxin, putative | 0.0009 | 0.0846 | 0.3064 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0018 | 0.2763 | 0.2803 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0009 | 0.0846 | 0.3064 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0018 | 0.2763 | 0.2803 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0018 | 0.2763 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0009 | 0.0846 | 0.0859 |
Echinococcus multilocularis | dihydrolipoamide dehydrogenase | 0.0018 | 0.2763 | 0.2763 |
Brugia malayi | Thioredoxin reductase | 0.0051 | 0.9855 | 1 |
Echinococcus granulosus | Thioredoxin fold | 0.0009 | 0.0846 | 0.0846 |
Echinococcus granulosus | dihydrolipoamide dehydrogenase | 0.0018 | 0.2763 | 0.2763 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0018 | 0.2763 | 0.2803 |
Plasmodium falciparum | thioredoxin 1 | 0.0009 | 0.0846 | 0.0859 |
Toxoplasma gondii | pyruvate dehydrogenase complex subunit PDH-E3II | 0.0018 | 0.2763 | 0.2803 |
Plasmodium falciparum | dihydrolipoyl dehydrogenase, apicoplast | 0.0018 | 0.2763 | 0.2803 |
Trypanosoma cruzi | dihydrolipoyl dehydrogenase, putative | 0.0018 | 0.2763 | 0.2803 |
Chlamydia trachomatis | thioredoxin | 0.0009 | 0.0846 | 0.3064 |
Trichomonas vaginalis | thioredoxin m(mitochondrial)-type, putative | 0.0009 | 0.0846 | 0.3064 |
Onchocerca volvulus | 0.0005 | 0 | 0.5 | |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase, LpdB | 0.0018 | 0.2763 | 1 |
Plasmodium falciparum | thioredoxin reductase | 0.0018 | 0.2763 | 0.2803 |
Entamoeba histolytica | thioredoxin, putative | 0.0009 | 0.0846 | 1 |
Trichomonas vaginalis | thioredoxin, putative | 0.0009 | 0.0846 | 0.3064 |
Trichomonas vaginalis | thioredoxin, putative | 0.0009 | 0.0846 | 0.3064 |
Entamoeba histolytica | thioredoxin, putative | 0.0009 | 0.0846 | 1 |
Brugia malayi | alpha keto acid dehydrogenase complex, E3 component, lipoamide dehydrogenase | 0.0013 | 0.1764 | 0.179 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0018 | 0.2763 | 1 |
Trichomonas vaginalis | thioredoxin, putative | 0.0009 | 0.0846 | 0.3064 |
Leishmania major | dihydrolipoamide dehydrogenase, putative | 0.0018 | 0.2763 | 0.2803 |
Leishmania major | dihydrolipoamide dehydrogenase, putative | 0.0018 | 0.2763 | 0.2803 |
Entamoeba histolytica | thioredoxin, putative | 0.0009 | 0.0846 | 1 |
Schistosoma mansoni | thioredoxin 2 | 0.0009 | 0.0846 | 0.0846 |
Trichomonas vaginalis | thioredoxin m(mitochondrial)-type, putative | 0.0009 | 0.0846 | 0.3064 |
Trypanosoma brucei | dihydrolipoyl dehydrogenase | 0.0018 | 0.2763 | 0.2803 |
Trichomonas vaginalis | thioredoxin, putative | 0.0009 | 0.0846 | 0.3064 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0009 | 0.0846 | 0.3064 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0051 | 0.9855 | 1 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0051 | 1 | 1 |
Mycobacterium tuberculosis | Thioredoxin TrxC (TRX) (MPT46) | 0.0009 | 0.0846 | 0.0859 |
Trypanosoma cruzi | thioredoxin, putative | 0.0009 | 0.0846 | 0.0859 |
Trichomonas vaginalis | thioredoxin, putative | 0.0009 | 0.0846 | 0.3064 |
Plasmodium falciparum | dihydrolipoyl dehydrogenase, mitochondrial | 0.0018 | 0.2763 | 0.2803 |
Mycobacterium tuberculosis | Probable soluble pyridine nucleotide transhydrogenase SthA (STH) (NAD(P)(+) transhydrogenase [B-specific]) (nicotinamide nucleot | 0.0018 | 0.2763 | 0.2803 |
Mycobacterium leprae | THIOREDOXIN TRXC (TRX) (MPT46) | 0.0005 | 0.0004 | 0.0013 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0051 | 0.9855 | 1 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0018 | 0.2763 | 0.2803 |
Brugia malayi | glutathione reductase | 0.0051 | 0.9855 | 1 |
Echinococcus granulosus | thioredoxin 1 | 0.0009 | 0.0846 | 0.0846 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase | 0.0018 | 0.2763 | 1 |
Trichomonas vaginalis | thioredoxin, putative | 0.0009 | 0.0846 | 0.3064 |
Toxoplasma gondii | NADPH-glutathione reductase | 0.0018 | 0.2763 | 0.2803 |
Trichomonas vaginalis | thioredoxin m(mitochondrial)-type, putative | 0.0009 | 0.0846 | 0.3064 |
Leishmania major | acetoin dehydrogenase e3 component-like protein | 0.0018 | 0.2763 | 0.2803 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase, point mutation | 0.0018 | 0.2763 | 0.2803 |
Trichomonas vaginalis | thioredoxin, putative | 0.0009 | 0.0846 | 0.3064 |
Leishmania major | thioredoxin, putative | 0.0009 | 0.0846 | 0.0859 |
Trichomonas vaginalis | thioredoxin, putative | 0.0009 | 0.0846 | 0.3064 |
Trichomonas vaginalis | thioredoxin, putative | 0.0009 | 0.0846 | 0.3064 |
Toxoplasma gondii | thioredoxin, putative | 0.0009 | 0.0846 | 0.0859 |
Plasmodium vivax | dihydrolipoyl dehydrogenase, mitochondrial, putative | 0.0018 | 0.2763 | 0.2803 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0051 | 0.9855 | 1 |
Treponema pallidum | NADH oxidase | 0.0018 | 0.2763 | 1 |
Loa Loa (eye worm) | glutathione reductase | 0.0051 | 0.9855 | 1 |
Trichomonas vaginalis | thioredoxin, putative | 0.0009 | 0.0846 | 0.3064 |
Echinococcus granulosus | thioredoxin | 0.0009 | 0.0846 | 0.0846 |
Schistosoma mansoni | thioredoxin | 0.0009 | 0.0846 | 0.0846 |
Trichomonas vaginalis | thioredoxin, putative | 0.0009 | 0.0846 | 0.3064 |
Leishmania major | trypanothione reductase | 0.0051 | 0.9855 | 1 |
Trypanosoma cruzi | dihydrolipoyl dehydrogenase, putative | 0.0018 | 0.2763 | 0.2803 |
Trichomonas vaginalis | thioredoxin, putative | 0.0009 | 0.0846 | 0.3064 |
Echinococcus multilocularis | thioredoxin | 0.0009 | 0.0846 | 0.0846 |
Trypanosoma cruzi | thioredoxin, putative | 0.0009 | 0.0846 | 0.0859 |
Trichomonas vaginalis | glutathione reductase, putative | 0.0018 | 0.2763 | 1 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase | 0.0018 | 0.2763 | 0.2803 |
Trypanosoma brucei | thioredoxin | 0.0009 | 0.0846 | 0.0859 |
Echinococcus multilocularis | thioredoxin 1 | 0.0009 | 0.0846 | 0.0846 |
Wolbachia endosymbiont of Brugia malayi | thioredoxin | 0.0009 | 0.0846 | 0.3064 |
Trichomonas vaginalis | thioredoxin, putative | 0.0009 | 0.0846 | 0.3064 |
Plasmodium falciparum | glutathione reductase | 0.0018 | 0.2763 | 0.2803 |
Toxoplasma gondii | thioredoxin-like protein TLP1 | 0.0009 | 0.0846 | 0.0859 |
Mycobacterium ulcerans | thioredoxin TrxB1 | 0.0009 | 0.0846 | 0.3064 |
Trichomonas vaginalis | thioredoxin f-type, putative | 0.0009 | 0.0846 | 0.3064 |
Giardia lamblia | NADH oxidase lateral transfer candidate | 0.0018 | 0.2763 | 1 |
Trichomonas vaginalis | thioredoxin m(mitochondrial)-type, putative | 0.0009 | 0.0846 | 0.3064 |
Echinococcus multilocularis | thioredoxin 2 | 0.0009 | 0.0846 | 0.0846 |
Treponema pallidum | thioredoxin (trx) | 0.0009 | 0.0846 | 0.3064 |
Plasmodium vivax | glutathione reductase, putative | 0.0051 | 0.9855 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0009 | 0.0846 | 0.3064 |
Plasmodium vivax | dihydrolipoyl dehydrogenase, apicoplast, putative | 0.0018 | 0.2763 | 0.2803 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0018 | 0.2763 | 1 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0018 | 0.2763 | 0.2803 |
Trichomonas vaginalis | thioredoxin f-type, putative | 0.0009 | 0.0846 | 0.3064 |
Mycobacterium ulcerans | thioredoxin TrxB1 | 0.0009 | 0.0846 | 0.3064 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0018 | 0.2763 | 0.2803 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase | 0.0018 | 0.2763 | 0.2803 |
Echinococcus multilocularis | thioredoxin, mitochondrial | 0.0009 | 0.0846 | 0.0846 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0009 | 0.0846 | 0.3064 |
Trichomonas vaginalis | thioredoxin, putative | 0.0009 | 0.0846 | 0.3064 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.